nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Carboplatin—breast cancer	0.246	1	CbGbCtD
Cefdinir—SLC22A5—Organic cation transport—SLC22A18—breast cancer	0.00979	0.0733	CbGpPWpGaD
Cefdinir—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.00664	0.0497	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL24—breast cancer	0.0047	0.0351	CbGpPWpGaD
Cefdinir—SLC15A2—mammary gland—breast cancer	0.00343	0.068	CbGeAlD
Cefdinir—SLC15A1—epithelium—breast cancer	0.00306	0.0605	CbGeAlD
Cefdinir—SLC22A5—mammary gland—breast cancer	0.00298	0.0591	CbGeAlD
Cefdinir—MPO—C-MYB transcription factor network—ETS2—breast cancer	0.00294	0.022	CbGpPWpGaD
Cefdinir—MPO—epithelium—breast cancer	0.00275	0.0545	CbGeAlD
Cefdinir—SLC15A1—endometrium—breast cancer	0.00274	0.0543	CbGeAlD
Cefdinir—MPO—Folate Metabolism—SHMT1—breast cancer	0.0027	0.0202	CbGpPWpGaD
Cefdinir—MPO—skin of body—breast cancer	0.00261	0.0518	CbGeAlD
Cefdinir—SLC22A5—nipple—breast cancer	0.00247	0.0489	CbGeAlD
Cefdinir—MPO—pituitary gland—breast cancer	0.00223	0.0442	CbGeAlD
Cefdinir—MPO—adrenal gland—breast cancer	0.00199	0.0395	CbGeAlD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00196	0.0146	CbGpPWpGaD
Cefdinir—MPO—bone marrow—breast cancer	0.00193	0.0382	CbGeAlD
Cefdinir—SLC15A1—endocrine gland—breast cancer	0.00192	0.0381	CbGeAlD
Cefdinir—MPO—C-MYB transcription factor network—PIM1—breast cancer	0.00185	0.0138	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A7—breast cancer	0.00182	0.0136	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00176	0.0131	CbGpPWpGaD
Cefdinir—MPO—endocrine gland—breast cancer	0.00173	0.0342	CbGeAlD
Cefdinir—SLC15A2—endometrium—breast cancer	0.00171	0.0339	CbGeAlD
Cefdinir—MPO—Folate Metabolism—GPX2—breast cancer	0.0017	0.0127	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—GPX4—breast cancer	0.00168	0.0125	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CSF1—breast cancer	0.00164	0.0122	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTR—breast cancer	0.00162	0.0121	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—HBA1—breast cancer	0.00158	0.0118	CbGpPWpGaD
Cefdinir—SLC22A5—skin of body—breast cancer	0.00158	0.0313	CbGeAlD
Cefdinir—MPO—C-MYB transcription factor network—CSF1R—breast cancer	0.00157	0.0117	CbGpPWpGaD
Cefdinir—SLC15A2—pituitary gland—breast cancer	0.00155	0.0307	CbGeAlD
Cefdinir—SLC22A5—endometrium—breast cancer	0.00149	0.0295	CbGeAlD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00145	0.0109	CbGpPWpGaD
Cefdinir—SLC15A2—female reproductive system—breast cancer	0.00142	0.0281	CbGeAlD
Cefdinir—SLC15A2—adrenal gland—breast cancer	0.00138	0.0274	CbGeAlD
Cefdinir—MPO—IL23-mediated signaling events—STAT5A—breast cancer	0.00135	0.0101	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—GPX2—breast cancer	0.00135	0.0101	CbGpPWpGaD
Cefdinir—SLC22A5—pituitary gland—breast cancer	0.00135	0.0267	CbGeAlD
Cefdinir—SLC22A5—adipose tissue—breast cancer	0.00134	0.0266	CbGeAlD
Cefdinir—MPO—Selenium Micronutrient Network—GPX4—breast cancer	0.00133	0.00996	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00133	0.00995	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTR—breast cancer	0.00132	0.00987	CbGpPWpGaD
Cefdinir—SLC15A2—female gonad—breast cancer	0.00129	0.0256	CbGeAlD
Cefdinir—MPO—Folate Metabolism—HBA1—breast cancer	0.00129	0.00962	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00128	0.00958	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CD34—breast cancer	0.00128	0.00958	CbGpPWpGaD
Cefdinir—SLC22A5—female reproductive system—breast cancer	0.00123	0.0245	CbGeAlD
Cefdinir—SLC22A5—adrenal gland—breast cancer	0.0012	0.0239	CbGeAlD
Cefdinir—SLC15A2—endocrine gland—breast cancer	0.0012	0.0238	CbGeAlD
Cefdinir—MPO—C-MYB transcription factor network—TAB2—breast cancer	0.0012	0.00898	CbGpPWpGaD
Cefdinir—MPO—lymph node—breast cancer	0.00119	0.0237	CbGeAlD
Cefdinir—MPO—Vitamin B12 Metabolism—PLG—breast cancer	0.00114	0.00855	CbGpPWpGaD
Cefdinir—SLC22A5—female gonad—breast cancer	0.00112	0.0222	CbGeAlD
Cefdinir—MPO—C-MYB transcription factor network—WNT1—breast cancer	0.00112	0.00837	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.0011	0.00825	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—MTR—breast cancer	0.00105	0.00784	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—HBA1—breast cancer	0.00102	0.00764	CbGpPWpGaD
Cefdinir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.00101	0.00753	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SOD2—breast cancer	0.000987	0.00738	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—breast cancer	0.000974	0.00729	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NFKBIA—breast cancer	0.000974	0.00729	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000956	0.00715	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GATA3—breast cancer	0.000951	0.00712	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS1—breast cancer	0.000935	0.00699	CbGpPWpGaD
Cefdinir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—breast cancer	0.000934	0.00699	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—PLG—breast cancer	0.00093	0.00696	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000887	0.00664	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000874	0.00654	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000874	0.00654	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000872	0.00653	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—MTHFR—breast cancer	0.000869	0.0065	CbGpPWpGaD
Cefdinir—SLC15A2—lymph node—breast cancer	0.00083	0.0164	CbGeAlD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000811	0.00607	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000811	0.00607	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SOD2—breast cancer	0.000803	0.00601	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000798	0.00597	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000798	0.00597	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—GPX1—breast cancer	0.000766	0.00573	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IFNG—breast cancer	0.000747	0.00559	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PLG—breast cancer	0.000739	0.00553	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—RELA—breast cancer	0.000737	0.00551	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000724	0.00542	CbGpPWpGaD
Cefdinir—SLC22A5—lymph node—breast cancer	0.000722	0.0143	CbGeAlD
Cefdinir—MPO—IL23-mediated signaling events—CD4—breast cancer	0.000722	0.0054	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—MTHFR—breast cancer	0.000707	0.00529	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000672	0.00503	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL1B—breast cancer	0.000666	0.00499	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL2—breast cancer	0.000664	0.00497	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000663	0.00496	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—HES1—breast cancer	0.000663	0.00496	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000662	0.00496	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000661	0.00495	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—NCOR1—breast cancer	0.000659	0.00493	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—GSTM1—breast cancer	0.000659	0.00493	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SOD2—breast cancer	0.000638	0.00477	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000638	0.00477	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000638	0.00477	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—SERPINE1—breast cancer	0.000635	0.00475	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ALB—breast cancer	0.000633	0.00474	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000615	0.0046	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—GPX1—breast cancer	0.000608	0.00455	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000605	0.00452	CbGpPWpGaD
Cefdinir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.000593	0.00443	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000592	0.00443	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000592	0.00443	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000582	0.00435	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000582	0.00435	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IFNG—breast cancer	0.000578	0.00432	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—RELA—breast cancer	0.00057	0.00427	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—MTHFR—breast cancer	0.000561	0.0042	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—breast cancer	0.000559	0.00418	CbGpPWpGaD
Cefdinir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—breast cancer	0.00055	0.00411	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000549	0.00411	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—SERPINE1—breast cancer	0.000516	0.00386	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL1B—breast cancer	0.000516	0.00386	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ALB—breast cancer	0.000515	0.00385	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000509	0.00381	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000501	0.00375	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KIT—breast cancer	0.00049	0.00366	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000486	0.00363	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—breast cancer	0.000484	0.00362	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IFNG—breast cancer	0.00047	0.00352	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—RELA—breast cancer	0.000464	0.00347	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000451	0.00337	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000444	0.00332	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000444	0.00332	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000443	0.00332	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—PIK3CA—breast cancer	0.000441	0.0033	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL1B—breast cancer	0.000419	0.00314	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL2—breast cancer	0.000418	0.00313	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000412	0.00308	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000412	0.00308	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—SERPINE1—breast cancer	0.00041	0.00307	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ALB—breast cancer	0.000409	0.00306	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000405	0.00303	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000405	0.00303	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—BCL2—breast cancer	0.000391	0.00293	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—breast cancer	0.00039	0.00292	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CD4—breast cancer	0.000374	0.0028	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—breast cancer	0.000374	0.0028	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IFNG—breast cancer	0.000374	0.00279	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—PTGS2—breast cancer	0.000372	0.00278	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—RELA—breast cancer	0.000369	0.00276	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—COX11—breast cancer	0.000368	0.00275	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000368	0.00275	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—PTGS2—breast cancer	0.000358	0.00268	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1B—breast cancer	0.000352	0.00263	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000342	0.00256	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000342	0.00256	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000337	0.00252	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—COX11—breast cancer	0.000336	0.00251	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000336	0.00251	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CCND1—breast cancer	0.000336	0.00251	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IL1B—breast cancer	0.000333	0.00249	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.00033	0.00247	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CDKN1A—breast cancer	0.000325	0.00243	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000324	0.00242	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000324	0.00242	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000312	0.00234	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000307	0.0023	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000306	0.00229	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TNF—breast cancer	0.000304	0.00228	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—breast cancer	0.000302	0.00226	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000301	0.00225	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000301	0.00225	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000301	0.00225	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000296	0.00221	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000296	0.00221	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000279	0.00209	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—MYC—breast cancer	0.000269	0.00202	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—TP53—breast cancer	0.000268	0.00201	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000265	0.00198	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000259	0.00194	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000256	0.00191	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000255	0.00191	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000255	0.0019	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—KRAS—breast cancer	0.000249	0.00186	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000246	0.00184	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL6—breast cancer	0.000246	0.00184	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—breast cancer	0.000242	0.00181	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000242	0.00181	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000237	0.00178	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000237	0.00177	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000237	0.00177	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000233	0.00175	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000233	0.00174	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.00022	0.00165	CbGpPWpGaD
Cefdinir—Body temperature increased—Mitoxantrone—breast cancer	0.000219	0.000384	CcSEcCtD
Cefdinir—Abdominal pain—Irinotecan—breast cancer	0.000219	0.000384	CcSEcCtD
Cefdinir—Abdominal pain—Mitoxantrone—breast cancer	0.000219	0.000384	CcSEcCtD
Cefdinir—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000219	0.000384	CcSEcCtD
Cefdinir—Aspartate aminotransferase increased—Doxorubicin—breast cancer	0.000219	0.000384	CcSEcCtD
Cefdinir—Pneumonia—Methotrexate—breast cancer	0.000217	0.000382	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000216	0.00162	CbGpPWpGaD
Cefdinir—Pancytopenia—Epirubicin—breast cancer	0.000216	0.000378	CcSEcCtD
Cefdinir—Anorexia—Paclitaxel—breast cancer	0.000215	0.000378	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000214	0.000376	CcSEcCtD
Cefdinir—Vomiting—Vinorelbine—breast cancer	0.000213	0.000375	CcSEcCtD
Cefdinir—Body temperature increased—Gemcitabine—breast cancer	0.000213	0.000374	CcSEcCtD
Cefdinir—Renal failure—Methotrexate—breast cancer	0.000213	0.000373	CcSEcCtD
Cefdinir—Neutropenia—Epirubicin—breast cancer	0.000212	0.000372	CcSEcCtD
Cefdinir—Dizziness—Thiotepa—breast cancer	0.000212	0.000372	CcSEcCtD
Cefdinir—MPO—C-MYB transcription factor network—HRAS—breast cancer	0.000212	0.00158	CbGpPWpGaD
Cefdinir—Rash—Vinorelbine—breast cancer	0.000212	0.000371	CcSEcCtD
Cefdinir—Dermatitis—Vinorelbine—breast cancer	0.000211	0.000371	CcSEcCtD
Cefdinir—Stomatitis—Methotrexate—breast cancer	0.000211	0.00037	CcSEcCtD
Cefdinir—Headache—Vinorelbine—breast cancer	0.00021	0.000369	CcSEcCtD
Cefdinir—Conjunctivitis—Methotrexate—breast cancer	0.00021	0.000369	CcSEcCtD
Cefdinir—Asthma—Doxorubicin—breast cancer	0.00021	0.000369	CcSEcCtD
Cefdinir—Leukopenia—Docetaxel—breast cancer	0.00021	0.000368	CcSEcCtD
Cefdinir—Body temperature increased—Fluorouracil—breast cancer	0.00021	0.000368	CcSEcCtD
Cefdinir—Haematuria—Methotrexate—breast cancer	0.000206	0.000362	CcSEcCtD
Cefdinir—Loss of consciousness—Docetaxel—breast cancer	0.000206	0.000362	CcSEcCtD
Cefdinir—Insomnia—Paclitaxel—breast cancer	0.000204	0.000358	CcSEcCtD
Cefdinir—Hypersensitivity—Mitoxantrone—breast cancer	0.000204	0.000358	CcSEcCtD
Cefdinir—Hypersensitivity—Irinotecan—breast cancer	0.000204	0.000358	CcSEcCtD
Cefdinir—Vomiting—Thiotepa—breast cancer	0.000204	0.000358	CcSEcCtD
Cefdinir—Pneumonia—Epirubicin—breast cancer	0.000204	0.000357	CcSEcCtD
Cefdinir—Leukopenia—Capecitabine—breast cancer	0.000203	0.000357	CcSEcCtD
Cefdinir—Convulsion—Docetaxel—breast cancer	0.000203	0.000357	CcSEcCtD
Cefdinir—Hypertension—Docetaxel—breast cancer	0.000202	0.000355	CcSEcCtD
Cefdinir—Rash—Thiotepa—breast cancer	0.000202	0.000355	CcSEcCtD
Cefdinir—Dermatitis—Thiotepa—breast cancer	0.000202	0.000354	CcSEcCtD
Cefdinir—Agranulocytosis—Methotrexate—breast cancer	0.000202	0.000354	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000202	0.00151	CbGpPWpGaD
Cefdinir—Headache—Thiotepa—breast cancer	0.000201	0.000352	CcSEcCtD
Cefdinir—Somnolence—Paclitaxel—breast cancer	0.000201	0.000352	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000201	0.000352	CcSEcCtD
Cefdinir—Chest pain—Docetaxel—breast cancer	0.0002	0.00035	CcSEcCtD
Cefdinir—Loss of consciousness—Capecitabine—breast cancer	0.000199	0.00035	CcSEcCtD
Cefdinir—Pancytopenia—Doxorubicin—breast cancer	0.000199	0.00035	CcSEcCtD
Cefdinir—Nausea—Vinorelbine—breast cancer	0.000199	0.00035	CcSEcCtD
Cefdinir—Renal failure—Epirubicin—breast cancer	0.000199	0.000349	CcSEcCtD
Cefdinir—Dyspepsia—Paclitaxel—breast cancer	0.000199	0.000349	CcSEcCtD
Cefdinir—Asthenia—Mitoxantrone—breast cancer	0.000199	0.000349	CcSEcCtD
Cefdinir—Asthenia—Irinotecan—breast cancer	0.000199	0.000349	CcSEcCtD
Cefdinir—Jaundice—Epirubicin—breast cancer	0.000197	0.000346	CcSEcCtD
Cefdinir—Stomatitis—Epirubicin—breast cancer	0.000197	0.000346	CcSEcCtD
Cefdinir—Conjunctivitis—Epirubicin—breast cancer	0.000197	0.000345	CcSEcCtD
Cefdinir—Neutropenia—Doxorubicin—breast cancer	0.000196	0.000345	CcSEcCtD
Cefdinir—Decreased appetite—Paclitaxel—breast cancer	0.000196	0.000344	CcSEcCtD
Cefdinir—Hypertension—Capecitabine—breast cancer	0.000196	0.000344	CcSEcCtD
Cefdinir—Hypersensitivity—Fluorouracil—breast cancer	0.000195	0.000343	CcSEcCtD
Cefdinir—Dry mouth—Docetaxel—breast cancer	0.000195	0.000343	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—breast cancer	0.000195	0.00146	CbGpPWpGaD
Cefdinir—Haemoglobin—Methotrexate—breast cancer	0.000195	0.000342	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000195	0.000342	CcSEcCtD
Cefdinir—Haemorrhage—Methotrexate—breast cancer	0.000194	0.000341	CcSEcCtD
Cefdinir—Asthenia—Gemcitabine—breast cancer	0.000193	0.00034	CcSEcCtD
Cefdinir—Chest pain—Capecitabine—breast cancer	0.000193	0.000339	CcSEcCtD
Cefdinir—Constipation—Paclitaxel—breast cancer	0.000193	0.000339	CcSEcCtD
Cefdinir—Haematuria—Epirubicin—breast cancer	0.000193	0.000339	CcSEcCtD
Cefdinir—Anaphylactic shock—Docetaxel—breast cancer	0.000191	0.000336	CcSEcCtD
Cefdinir—Pruritus—Gemcitabine—breast cancer	0.000191	0.000335	CcSEcCtD
Cefdinir—Nausea—Thiotepa—breast cancer	0.00019	0.000334	CcSEcCtD
Cefdinir—Diarrhoea—Mitoxantrone—breast cancer	0.000189	0.000332	CcSEcCtD
Cefdinir—Diarrhoea—Irinotecan—breast cancer	0.000189	0.000332	CcSEcCtD
Cefdinir—Dry mouth—Capecitabine—breast cancer	0.000189	0.000332	CcSEcCtD
Cefdinir—Agranulocytosis—Epirubicin—breast cancer	0.000189	0.000331	CcSEcCtD
Cefdinir—Pneumonia—Doxorubicin—breast cancer	0.000188	0.000331	CcSEcCtD
Cefdinir—Shock—Docetaxel—breast cancer	0.000188	0.00033	CcSEcCtD
Cefdinir—Pruritus—Fluorouracil—breast cancer	0.000188	0.000329	CcSEcCtD
Cefdinir—Thrombocytopenia—Docetaxel—breast cancer	0.000187	0.000329	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000187	0.0014	CbGpPWpGaD
Cefdinir—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000186	0.000326	CcSEcCtD
Cefdinir—Gastrointestinal pain—Paclitaxel—breast cancer	0.000185	0.000324	CcSEcCtD
Cefdinir—Diarrhoea—Gemcitabine—breast cancer	0.000184	0.000324	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000184	0.00138	CbGpPWpGaD
Cefdinir—Renal failure—Doxorubicin—breast cancer	0.000184	0.000323	CcSEcCtD
Cefdinir—Erythema multiforme—Methotrexate—breast cancer	0.000184	0.000322	CcSEcCtD
Cefdinir—Dizziness—Irinotecan—breast cancer	0.000183	0.000321	CcSEcCtD
Cefdinir—Haemoglobin—Epirubicin—breast cancer	0.000183	0.00032	CcSEcCtD
Cefdinir—Stomatitis—Doxorubicin—breast cancer	0.000182	0.00032	CcSEcCtD
Cefdinir—Jaundice—Doxorubicin—breast cancer	0.000182	0.00032	CcSEcCtD
Cefdinir—Anorexia—Docetaxel—breast cancer	0.000182	0.00032	CcSEcCtD
Cefdinir—Shock—Capecitabine—breast cancer	0.000182	0.00032	CcSEcCtD
Cefdinir—Conjunctivitis—Doxorubicin—breast cancer	0.000182	0.000319	CcSEcCtD
Cefdinir—Haemorrhage—Epirubicin—breast cancer	0.000182	0.000319	CcSEcCtD
Cefdinir—Diarrhoea—Fluorouracil—breast cancer	0.000181	0.000318	CcSEcCtD
Cefdinir—Thrombocytopenia—Capecitabine—breast cancer	0.000181	0.000318	CcSEcCtD
Cefdinir—Haematuria—Doxorubicin—breast cancer	0.000179	0.000313	CcSEcCtD
Cefdinir—Abdominal pain—Paclitaxel—breast cancer	0.000178	0.000313	CcSEcCtD
Cefdinir—Body temperature increased—Paclitaxel—breast cancer	0.000178	0.000313	CcSEcCtD
Cefdinir—Anorexia—Capecitabine—breast cancer	0.000177	0.00031	CcSEcCtD
Cefdinir—Vomiting—Mitoxantrone—breast cancer	0.000176	0.000309	CcSEcCtD
Cefdinir—Vomiting—Irinotecan—breast cancer	0.000176	0.000309	CcSEcCtD
Cefdinir—Dizziness—Fluorouracil—breast cancer	0.000175	0.000308	CcSEcCtD
Cefdinir—Agranulocytosis—Doxorubicin—breast cancer	0.000175	0.000307	CcSEcCtD
Cefdinir—Rash—Mitoxantrone—breast cancer	0.000175	0.000306	CcSEcCtD
Cefdinir—Rash—Irinotecan—breast cancer	0.000175	0.000306	CcSEcCtD
Cefdinir—Dermatitis—Mitoxantrone—breast cancer	0.000174	0.000306	CcSEcCtD
Cefdinir—Dermatitis—Irinotecan—breast cancer	0.000174	0.000306	CcSEcCtD
Cefdinir—Headache—Mitoxantrone—breast cancer	0.000173	0.000304	CcSEcCtD
Cefdinir—Headache—Irinotecan—breast cancer	0.000173	0.000304	CcSEcCtD
Cefdinir—Insomnia—Docetaxel—breast cancer	0.000173	0.000304	CcSEcCtD
Cefdinir—Erythema multiforme—Epirubicin—breast cancer	0.000172	0.000301	CcSEcCtD
Cefdinir—Vomiting—Gemcitabine—breast cancer	0.000171	0.000301	CcSEcCtD
Cefdinir—Somnolence—Docetaxel—breast cancer	0.00017	0.000299	CcSEcCtD
Cefdinir—Rash—Gemcitabine—breast cancer	0.00017	0.000298	CcSEcCtD
Cefdinir—Dermatitis—Gemcitabine—breast cancer	0.00017	0.000298	CcSEcCtD
Cefdinir—Haemoglobin—Doxorubicin—breast cancer	0.000169	0.000297	CcSEcCtD
Cefdinir—Headache—Gemcitabine—breast cancer	0.000169	0.000296	CcSEcCtD
Cefdinir—Vomiting—Fluorouracil—breast cancer	0.000169	0.000296	CcSEcCtD
Cefdinir—Dyspepsia—Docetaxel—breast cancer	0.000168	0.000296	CcSEcCtD
Cefdinir—Haemorrhage—Doxorubicin—breast cancer	0.000168	0.000295	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000168	0.00126	CbGpPWpGaD
Cefdinir—Insomnia—Capecitabine—breast cancer	0.000168	0.000294	CcSEcCtD
Cefdinir—Rash—Fluorouracil—breast cancer	0.000167	0.000293	CcSEcCtD
Cefdinir—Dermatitis—Fluorouracil—breast cancer	0.000167	0.000293	CcSEcCtD
Cefdinir—Decreased appetite—Docetaxel—breast cancer	0.000166	0.000292	CcSEcCtD
Cefdinir—Hypersensitivity—Paclitaxel—breast cancer	0.000166	0.000292	CcSEcCtD
Cefdinir—Headache—Fluorouracil—breast cancer	0.000166	0.000291	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Docetaxel—breast cancer	0.000165	0.00029	CcSEcCtD
Cefdinir—Nausea—Mitoxantrone—breast cancer	0.000164	0.000289	CcSEcCtD
Cefdinir—Nausea—Irinotecan—breast cancer	0.000164	0.000289	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000164	0.00123	CbGpPWpGaD
Cefdinir—Constipation—Docetaxel—breast cancer	0.000164	0.000287	CcSEcCtD
Cefdinir—Dyspepsia—Capecitabine—breast cancer	0.000163	0.000286	CcSEcCtD
Cefdinir—Asthenia—Paclitaxel—breast cancer	0.000162	0.000284	CcSEcCtD
Cefdinir—Decreased appetite—Capecitabine—breast cancer	0.000161	0.000283	CcSEcCtD
Cefdinir—Nausea—Gemcitabine—breast cancer	0.00016	0.000281	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Capecitabine—breast cancer	0.00016	0.000281	CcSEcCtD
Cefdinir—Pruritus—Paclitaxel—breast cancer	0.00016	0.00028	CcSEcCtD
Cefdinir—Erythema multiforme—Doxorubicin—breast cancer	0.000159	0.000279	CcSEcCtD
Cefdinir—Constipation—Capecitabine—breast cancer	0.000158	0.000278	CcSEcCtD
Cefdinir—Nausea—Fluorouracil—breast cancer	0.000157	0.000276	CcSEcCtD
Cefdinir—Gastrointestinal pain—Docetaxel—breast cancer	0.000156	0.000275	CcSEcCtD
Cefdinir—Flatulence—Epirubicin—breast cancer	0.000156	0.000273	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000156	0.00117	CbGpPWpGaD
Cefdinir—Diarrhoea—Paclitaxel—breast cancer	0.000154	0.000271	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000153	0.00115	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000153	0.00114	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Capecitabine—breast cancer	0.000151	0.000266	CcSEcCtD
Cefdinir—Body temperature increased—Docetaxel—breast cancer	0.000151	0.000265	CcSEcCtD
Cefdinir—Abdominal pain—Docetaxel—breast cancer	0.000151	0.000265	CcSEcCtD
Cefdinir—Leukopenia—Methotrexate—breast cancer	0.000151	0.000265	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00015	0.00112	CbGpPWpGaD
Cefdinir—Dizziness—Paclitaxel—breast cancer	0.000149	0.000262	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—TFRC—breast cancer	0.000147	0.0011	CbGpPWpGaD
Cefdinir—Abdominal pain—Capecitabine—breast cancer	0.000146	0.000257	CcSEcCtD
Cefdinir—Body temperature increased—Capecitabine—breast cancer	0.000146	0.000257	CcSEcCtD
Cefdinir—Convulsion—Methotrexate—breast cancer	0.000146	0.000257	CcSEcCtD
Cefdinir—Agitation—Epirubicin—breast cancer	0.000145	0.000255	CcSEcCtD
Cefdinir—Flatulence—Doxorubicin—breast cancer	0.000144	0.000253	CcSEcCtD
Cefdinir—Chest pain—Methotrexate—breast cancer	0.000144	0.000252	CcSEcCtD
Cefdinir—Vomiting—Paclitaxel—breast cancer	0.000144	0.000252	CcSEcCtD
Cefdinir—Rash—Paclitaxel—breast cancer	0.000142	0.00025	CcSEcCtD
Cefdinir—Dermatitis—Paclitaxel—breast cancer	0.000142	0.00025	CcSEcCtD
Cefdinir—Leukopenia—Epirubicin—breast cancer	0.000142	0.000248	CcSEcCtD
Cefdinir—Headache—Paclitaxel—breast cancer	0.000141	0.000248	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000141	0.00106	CbGpPWpGaD
Cefdinir—Hypersensitivity—Docetaxel—breast cancer	0.000141	0.000247	CcSEcCtD
Cefdinir—Loss of consciousness—Epirubicin—breast cancer	0.000139	0.000244	CcSEcCtD
Cefdinir—Anaphylactic shock—Methotrexate—breast cancer	0.000138	0.000242	CcSEcCtD
Cefdinir—Asthenia—Docetaxel—breast cancer	0.000137	0.000241	CcSEcCtD
Cefdinir—Convulsion—Epirubicin—breast cancer	0.000137	0.00024	CcSEcCtD
Cefdinir—Hypertension—Epirubicin—breast cancer	0.000137	0.00024	CcSEcCtD
Cefdinir—Hypersensitivity—Capecitabine—breast cancer	0.000136	0.00024	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.000136	0.00102	CbGpPWpGaD
Cefdinir—Pruritus—Docetaxel—breast cancer	0.000135	0.000238	CcSEcCtD
Cefdinir—Thrombocytopenia—Methotrexate—breast cancer	0.000135	0.000237	CcSEcCtD
Cefdinir—Chest pain—Epirubicin—breast cancer	0.000135	0.000236	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000135	0.00101	CbGpPWpGaD
Cefdinir—Agitation—Doxorubicin—breast cancer	0.000134	0.000236	CcSEcCtD
Cefdinir—Nausea—Paclitaxel—breast cancer	0.000134	0.000235	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—TFRC—breast cancer	0.000134	0.001	CbGpPWpGaD
Cefdinir—Asthenia—Capecitabine—breast cancer	0.000133	0.000233	CcSEcCtD
Cefdinir—Dry mouth—Epirubicin—breast cancer	0.000132	0.000231	CcSEcCtD
Cefdinir—Anorexia—Methotrexate—breast cancer	0.000131	0.000231	CcSEcCtD
Cefdinir—Pruritus—Capecitabine—breast cancer	0.000131	0.00023	CcSEcCtD
Cefdinir—Leukopenia—Doxorubicin—breast cancer	0.000131	0.00023	CcSEcCtD
Cefdinir—Diarrhoea—Docetaxel—breast cancer	0.000131	0.00023	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000131	0.000979	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.00013	0.000972	CbGpPWpGaD
Cefdinir—Anaphylactic shock—Epirubicin—breast cancer	0.000129	0.000227	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000129	0.000963	CbGpPWpGaD
Cefdinir—Loss of consciousness—Doxorubicin—breast cancer	0.000129	0.000226	CcSEcCtD
Cefdinir—Shock—Epirubicin—breast cancer	0.000127	0.000223	CcSEcCtD
Cefdinir—Convulsion—Doxorubicin—breast cancer	0.000127	0.000223	CcSEcCtD
Cefdinir—Diarrhoea—Capecitabine—breast cancer	0.000127	0.000222	CcSEcCtD
Cefdinir—Dizziness—Docetaxel—breast cancer	0.000127	0.000222	CcSEcCtD
Cefdinir—Thrombocytopenia—Epirubicin—breast cancer	0.000126	0.000222	CcSEcCtD
Cefdinir—Hypertension—Doxorubicin—breast cancer	0.000126	0.000222	CcSEcCtD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—ALB—breast cancer	0.000126	0.000945	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000125	0.000934	CbGpPWpGaD
Cefdinir—Insomnia—Methotrexate—breast cancer	0.000125	0.000219	CcSEcCtD
Cefdinir—Chest pain—Doxorubicin—breast cancer	0.000125	0.000219	CcSEcCtD
Cefdinir—Anorexia—Epirubicin—breast cancer	0.000123	0.000216	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000123	0.000919	CbGpPWpGaD
Cefdinir—Somnolence—Methotrexate—breast cancer	0.000123	0.000215	CcSEcCtD
Cefdinir—Dizziness—Capecitabine—breast cancer	0.000122	0.000215	CcSEcCtD
Cefdinir—Dry mouth—Doxorubicin—breast cancer	0.000122	0.000214	CcSEcCtD
Cefdinir—Vomiting—Docetaxel—breast cancer	0.000122	0.000214	CcSEcCtD
Cefdinir—Dyspepsia—Methotrexate—breast cancer	0.000121	0.000213	CcSEcCtD
Cefdinir—Rash—Docetaxel—breast cancer	0.000121	0.000212	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000121	0.000902	CbGpPWpGaD
Cefdinir—Dermatitis—Docetaxel—breast cancer	0.000121	0.000212	CcSEcCtD
Cefdinir—Decreased appetite—Methotrexate—breast cancer	0.00012	0.00021	CcSEcCtD
Cefdinir—Headache—Docetaxel—breast cancer	0.00012	0.00021	CcSEcCtD
Cefdinir—Anaphylactic shock—Doxorubicin—breast cancer	0.000119	0.00021	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Methotrexate—breast cancer	0.000119	0.000209	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000119	0.000889	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000119	0.000887	CbGpPWpGaD
Cefdinir—Vomiting—Capecitabine—breast cancer	0.000118	0.000207	CcSEcCtD
Cefdinir—Shock—Doxorubicin—breast cancer	0.000117	0.000206	CcSEcCtD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000117	0.000877	CbGpPWpGaD
Cefdinir—Thrombocytopenia—Doxorubicin—breast cancer	0.000117	0.000205	CcSEcCtD
Cefdinir—Rash—Capecitabine—breast cancer	0.000117	0.000205	CcSEcCtD
Cefdinir—Insomnia—Epirubicin—breast cancer	0.000117	0.000205	CcSEcCtD
Cefdinir—Dermatitis—Capecitabine—breast cancer	0.000117	0.000205	CcSEcCtD
Cefdinir—Headache—Capecitabine—breast cancer	0.000116	0.000204	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—PLG—breast cancer	0.000116	0.000866	CbGpPWpGaD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—ALB—breast cancer	0.000115	0.000862	CbGpPWpGaD
Cefdinir—Somnolence—Epirubicin—breast cancer	0.000115	0.000201	CcSEcCtD
Cefdinir—Anorexia—Doxorubicin—breast cancer	0.000114	0.0002	CcSEcCtD
Cefdinir—Nausea—Docetaxel—breast cancer	0.000114	0.000199	CcSEcCtD
Cefdinir—Dyspepsia—Epirubicin—breast cancer	0.000114	0.000199	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methotrexate—breast cancer	0.000113	0.000198	CcSEcCtD
Cefdinir—Decreased appetite—Epirubicin—breast cancer	0.000112	0.000197	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Epirubicin—breast cancer	0.000111	0.000196	CcSEcCtD
Cefdinir—Constipation—Epirubicin—breast cancer	0.00011	0.000194	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.00011	0.000825	CbGpPWpGaD
Cefdinir—Nausea—Capecitabine—breast cancer	0.00011	0.000193	CcSEcCtD
Cefdinir—Abdominal pain—Methotrexate—breast cancer	0.000109	0.000191	CcSEcCtD
Cefdinir—Body temperature increased—Methotrexate—breast cancer	0.000109	0.000191	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—NCOA1—breast cancer	0.000108	0.000812	CbGpPWpGaD
Cefdinir—Insomnia—Doxorubicin—breast cancer	0.000108	0.00019	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000107	0.000804	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000107	0.0008	CbGpPWpGaD
Cefdinir—Somnolence—Doxorubicin—breast cancer	0.000106	0.000186	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—PLG—breast cancer	0.000106	0.000791	CbGpPWpGaD
Cefdinir—Gastrointestinal pain—Epirubicin—breast cancer	0.000106	0.000185	CcSEcCtD
Cefdinir—Dyspepsia—Doxorubicin—breast cancer	0.000105	0.000184	CcSEcCtD
Cefdinir—Decreased appetite—Doxorubicin—breast cancer	0.000104	0.000182	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000103	0.000181	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000103	0.000768	CbGpPWpGaD
Cefdinir—Constipation—Doxorubicin—breast cancer	0.000102	0.000179	CcSEcCtD
Cefdinir—Body temperature increased—Epirubicin—breast cancer	0.000102	0.000179	CcSEcCtD
Cefdinir—Abdominal pain—Epirubicin—breast cancer	0.000102	0.000179	CcSEcCtD
Cefdinir—Hypersensitivity—Methotrexate—breast cancer	0.000102	0.000178	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—HMOX1—breast cancer	9.92e-05	0.000742	CbGpPWpGaD
Cefdinir—Asthenia—Methotrexate—breast cancer	9.89e-05	0.000174	CcSEcCtD
Cefdinir—Gastrointestinal pain—Doxorubicin—breast cancer	9.76e-05	0.000171	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—HMOX1—breast cancer	9.76e-05	0.00073	CbGpPWpGaD
Cefdinir—Pruritus—Methotrexate—breast cancer	9.76e-05	0.000171	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ABCB1—breast cancer	9.52e-05	0.000712	CbGpPWpGaD
Cefdinir—Hypersensitivity—Epirubicin—breast cancer	9.51e-05	0.000167	CcSEcCtD
Cefdinir—Abdominal pain—Doxorubicin—breast cancer	9.44e-05	0.000166	CcSEcCtD
Cefdinir—Body temperature increased—Doxorubicin—breast cancer	9.44e-05	0.000166	CcSEcCtD
Cefdinir—Diarrhoea—Methotrexate—breast cancer	9.43e-05	0.000166	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ABCB1—breast cancer	9.36e-05	0.000701	CbGpPWpGaD
Cefdinir—Asthenia—Epirubicin—breast cancer	9.26e-05	0.000163	CcSEcCtD
Cefdinir—Pruritus—Epirubicin—breast cancer	9.13e-05	0.00016	CcSEcCtD
Cefdinir—Dizziness—Methotrexate—breast cancer	9.12e-05	0.00016	CcSEcCtD
Cefdinir—Diarrhoea—Epirubicin—breast cancer	8.83e-05	0.000155	CcSEcCtD
Cefdinir—Hypersensitivity—Doxorubicin—breast cancer	8.8e-05	0.000154	CcSEcCtD
Cefdinir—Vomiting—Methotrexate—breast cancer	8.77e-05	0.000154	CcSEcCtD
Cefdinir—Rash—Methotrexate—breast cancer	8.69e-05	0.000153	CcSEcCtD
Cefdinir—Dermatitis—Methotrexate—breast cancer	8.69e-05	0.000152	CcSEcCtD
Cefdinir—Headache—Methotrexate—breast cancer	8.64e-05	0.000152	CcSEcCtD
Cefdinir—Asthenia—Doxorubicin—breast cancer	8.57e-05	0.00015	CcSEcCtD
Cefdinir—Dizziness—Epirubicin—breast cancer	8.53e-05	0.00015	CcSEcCtD
Cefdinir—Pruritus—Doxorubicin—breast cancer	8.45e-05	0.000148	CcSEcCtD
Cefdinir—Vomiting—Epirubicin—breast cancer	8.2e-05	0.000144	CcSEcCtD
Cefdinir—Nausea—Methotrexate—breast cancer	8.19e-05	0.000144	CcSEcCtD
Cefdinir—Diarrhoea—Doxorubicin—breast cancer	8.17e-05	0.000143	CcSEcCtD
Cefdinir—Rash—Epirubicin—breast cancer	8.14e-05	0.000143	CcSEcCtD
Cefdinir—Dermatitis—Epirubicin—breast cancer	8.13e-05	0.000143	CcSEcCtD
Cefdinir—Headache—Epirubicin—breast cancer	8.08e-05	0.000142	CcSEcCtD
Cefdinir—Dizziness—Doxorubicin—breast cancer	7.9e-05	0.000139	CcSEcCtD
Cefdinir—Nausea—Epirubicin—breast cancer	7.67e-05	0.000135	CcSEcCtD
Cefdinir—Vomiting—Doxorubicin—breast cancer	7.59e-05	0.000133	CcSEcCtD
Cefdinir—Rash—Doxorubicin—breast cancer	7.53e-05	0.000132	CcSEcCtD
Cefdinir—Dermatitis—Doxorubicin—breast cancer	7.52e-05	0.000132	CcSEcCtD
Cefdinir—Headache—Doxorubicin—breast cancer	7.48e-05	0.000131	CcSEcCtD
Cefdinir—Nausea—Doxorubicin—breast cancer	7.09e-05	0.000124	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—ALB—breast cancer	6.42e-05	0.00048	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—ALB—breast cancer	5.96e-05	0.000446	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	5.86e-05	0.000438	CbGpPWpGaD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—RAF1—breast cancer	5.8e-05	0.000434	CbGpPWpGaD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—RAF1—breast cancer	5.39e-05	0.000403	CbGpPWpGaD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	5.3e-05	0.000396	CbGpPWpGaD
Cefdinir—Cefradine—CYP3A4—breast cancer	2.08e-05	0.198	CrCbGaD
Cefdinir—Cephalexin—CYP2D6—breast cancer	1.57e-05	0.15	CrCbGaD
Cefdinir—Cefazolin—ALB—breast cancer	1.55e-05	0.148	CrCbGaD
Cefdinir—Ceftriaxone—ALB—breast cancer	1.47e-05	0.141	CrCbGaD
Cefdinir—Cephalexin—CYP3A4—breast cancer	1.34e-05	0.128	CrCbGaD
Cefdinir—Cefalotin—ALB—breast cancer	1.29e-05	0.123	CrCbGaD
Cefdinir—Cephalexin—ALB—breast cancer	1.17e-05	0.112	CrCbGaD
